Understand any stock in simple English
Enter a ticker to learn what the company does and how it makes money.
Carl Zeiss Meditec makes high-tech machines and tools that eye doctors and surgeons use to diagnose and treat eye problems and perform brain and other surgeries.
Carl Zeiss Meditec makes the expensive, specialized machines that eye doctors and surgeons rely on. If you've ever had your eyes checked for glasses or been told you need cataract surgery, there's a decent chance the equipment involved came from this company. It sells diagnostic devices like machines that scan the retina or map the shape of the eye, and it sells surgical systems that surgeons use during operations, including the tools used in cataract and refractive eye surgery.
The company is split into two main parts. The larger one is its ophthalmology business, which sells to eye clinics, hospitals, and private practices — both the diagnostic gear that finds problems and the surgical kit that fixes them. The other part, its microsurgery business, sells surgical microscopes and instruments that surgeons use in brain surgery, ear, nose, and throat procedures, and other delicate operations where seeing tiny structures clearly is the whole game. Hospitals and surgeons pay for the machines themselves, and often for the software, service contracts, and replacement parts that keep them running. The story goes back to the famous German optics firm founded by Carl Zeiss in the nineteenth century, whose lenses and precision instruments became a byword for quality. The medical-technology piece was eventually spun out as its own publicly traded company, listed on the Frankfurt exchange. Its customers pick it because in medicine, being a little more precise than the other guy can be the difference between a good outcome and a bad one — and hospitals tend to stick with equipment and brands they already trust.
The business has real strengths and real weak spots. Replacing these machines is a big purchase for a hospital, so sales can slow when budgets tighten, and the company has to keep spending heavily on research to stay ahead of rivals in eye care and surgical imaging. A big part of its growth story is Asia, particularly China, where a rising middle class and more eye care spending have driven demand — but that also makes it sensitive to shifts in Chinese hospital purchasing and government policy.
Saved answer · last researched 25 Oct 2026